60 DEGREES PHARMA INC
SXTP · NASDAQ
Updated at 2026-10-14 09:34:49
- Today's High
- $0.94
- Today’s Low
- $0.87
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $0.93
- Previous Close
- $0.91
- Volume
- 38.23K
- Market Cap
- $3.22M
- P/E Ratio
- --
- EPS
- $-5.93
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 1025 CONNECTICUT AVENUE NW, WASHINGTON, DC, UNITED STATES, 20036
- Country
- US
- Listing Date
- 2023-07-12
- Fiscal Year End
- December
- Shares Outstanding
- 2.66M
- CIK
- 0001946563
- Website
- 60degreespharma.com
60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company is headquartered in Washington, District of Columbia.
Financial Metrics
Revenue
2026-06-30
$207.89K
2026-03-31
$162.09K
2025-12-31
$303.38K
2025-09-30
$437.6K
Operating Expenses
2026-06-30
$2.32M
2026-03-31
$2.17M
2025-12-31
$2.1M
2025-09-30
$2.22M
Net Income
2026-06-30
-$2.26M
2026-03-31
-$2.09M
2025-12-31
-$1.44M
2025-09-30
-$2.31M
Net Profit Margin
2026-06-30
-1.08K%
2026-03-31
-1.28K%
2025-12-31
-474.97%
2025-09-30
-529.48%
Earnings Per Share
2026-06-30
$-0.90
2026-03-31
$-1.21
2025-12-31
$-8.17
2025-09-30
$-2.53
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$2.23M
2026-03-31
-$2.06M
2025-12-31
-$1.41M
2025-09-30
-$2.29M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
0.12%
2025-09-30
-0.01%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $207.89K | $162.09K | $303.38K | $437.6K |
| Operating Expenses | $2.32M | $2.17M | $2.1M | $2.22M |
| Net Income | -$2.26M | -$2.09M | -$1.44M | -$2.31M |
| Net Profit Margin | -1.08K% | -1.28K% | -474.97% | -529.48% |
| Earnings Per Share | $-0.90 | $-1.21 | $-8.17 | $-2.53 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$2.23M | -$2.06M | -$1.41M | -$2.29M |
| Effective Tax Rate | -- | -- | 0.12% | -0.01% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.